Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SSUTRO BIOPHARMA, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

SUTRO BIOPHARMA, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $9.84M. Net result −$38.53M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $9.84M. Running result $9.84M. Revenue: $9.84M.
  • Cost of revenue: $0. Running result $9.84M.
  • Gross profit: $9.84M. Running result $9.84M.
  • Research and development: −$31.7M. Running result −$21.86M.
  • General and administrative: −$7.83M. Running result −$29.69M.
  • Restructuring and related costs: −$201K. Running result −$29.89M.
  • Operating income: −$29.89M. Running result −$29.89M.
  • Other expense: −$8.64M. Running result −$38.53M.
  • Pre-tax loss: −$38.53M. Running result −$38.53M.
  • Income tax expense: −$1K. Running result −$38.53M.
  • Net loss: −$38.53M. Running result −$38.53M.